Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200

Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Diabetic Foot Ulcer Neuropathic Interventions:   Biological: hOMSC200;   Other: Placebo Sponsor:   Cytora Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials